RxDoctor Payments Data

Jeffrey Kamo, OD

Corneal and Contact Management · Berkeley, CANPI 1104503432

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,338 of the $3,619 with a category attached, or 64.6%. 9 manufacturers reported payments, led by Lumenis BE Inc at 30.3% of the total. 2025 is the largest year on record at $1,819, 2.9 times the $630 reported in 2023.

$3,619in general payments, 2019–2025

Across 56 payments — averaging $64.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lumenis BE Inc$1K
  • Alcon$617
  • Coopervision Inc.$571
  • Johnson & Johnson Vision Care, Inc.$495
  • Bausch & Lomb Americas Inc.$308
  • Carl Zeiss Meditec, Inc.$230
  • plus $301 from 3 others

What the payments were for

  • Consulting fees$80022%
  • Speaking & faculty fees$40011%
  • Travel & lodging$812%
  • Food & beverage$2,33865%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,619 in reported general payments places this provider in the 75th percentile of 140 corneal and contact management providers in California.

See all corneal and contact management providers in California

Medicare billing

Part B allowed, 2024
$4,699
Medicare patients
28
Services billed
54

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other corneal and contact management in Berkeley

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →